ZA200801945B - Novelimidazolecarboxamide derivatives as fructose-1,6-bisphosphatase inhibitors, and pharmaceutical compositions comprising same - Google Patents
Novelimidazolecarboxamide derivatives as fructose-1,6-bisphosphatase inhibitors, and pharmaceutical compositions comprising sameInfo
- Publication number
- ZA200801945B ZA200801945B ZA200801945A ZA200801945A ZA200801945B ZA 200801945 B ZA200801945 B ZA 200801945B ZA 200801945 A ZA200801945 A ZA 200801945A ZA 200801945 A ZA200801945 A ZA 200801945A ZA 200801945 B ZA200801945 B ZA 200801945B
- Authority
- ZA
- South Africa
- Prior art keywords
- novelimidazolecarboxamide
- fructose
- derivatives
- same
- pharmaceutical compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0508211A FR2889190A1 (fr) | 2005-08-01 | 2005-08-01 | Nouveaux derives d'imidazoles carboxamides comme inhibiteurs de fructose -1,6-biphosphatase et compositions pharmaceutiques les contenant |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200801945B true ZA200801945B (en) | 2009-08-26 |
Family
ID=36168401
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200801945A ZA200801945B (en) | 2005-08-01 | 2008-02-29 | Novelimidazolecarboxamide derivatives as fructose-1,6-bisphosphatase inhibitors, and pharmaceutical compositions comprising same |
Country Status (16)
Country | Link |
---|---|
US (1) | US8362057B2 (de) |
EP (1) | EP1910310B1 (de) |
JP (1) | JP5026421B2 (de) |
KR (1) | KR20080033489A (de) |
CN (1) | CN101233114A (de) |
AR (1) | AR055202A1 (de) |
AT (1) | ATE432925T1 (de) |
AU (1) | AU2006275172B2 (de) |
BR (1) | BRPI0614496A2 (de) |
CA (1) | CA2617282C (de) |
DE (1) | DE602006007148D1 (de) |
ES (1) | ES2326237T3 (de) |
FR (1) | FR2889190A1 (de) |
MX (1) | MX2008001489A (de) |
WO (1) | WO2007014619A1 (de) |
ZA (1) | ZA200801945B (de) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2889190A1 (fr) | 2005-08-01 | 2007-02-02 | Merck Sante Soc Par Actions Si | Nouveaux derives d'imidazoles carboxamides comme inhibiteurs de fructose -1,6-biphosphatase et compositions pharmaceutiques les contenant |
EP2061767B1 (de) | 2006-08-08 | 2014-12-17 | Sanofi | Arylaminoaryl-alkyl-substituierte Imidazolidin-2,4-dione, Verfahren zu ihrer Herstellung, diese Verbindungen enthaltende Arzneimittel und ihre Verwendung |
EP2102199B1 (de) * | 2006-12-04 | 2011-04-27 | AstraZeneca AB | Antibakterielle polycyclische harnstoffverbindungen |
EP2025674A1 (de) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
DE102007047738A1 (de) * | 2007-10-05 | 2009-04-09 | Merck Patent Gmbh | Imidazolderivate |
US20110129440A1 (en) * | 2007-10-29 | 2011-06-02 | Schering Corporation | Heterocyclic Urea and Thiourea Derivatives and Methods of Use Thereof |
MX2010005714A (es) * | 2007-11-30 | 2010-07-01 | Hoffmann La Roche | Compuestos de piridina. |
TW201014822A (en) | 2008-07-09 | 2010-04-16 | Sanofi Aventis | Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof |
WO2010068601A1 (en) | 2008-12-08 | 2010-06-17 | Sanofi-Aventis | A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof |
DK2470552T3 (en) | 2009-08-26 | 2014-02-17 | Sanofi Sa | NOVEL, CRYSTALLINE, heteroaromatic FLUORGLYCOSIDHYDRATER, MEDICINES COVERING THESE COMPOUNDS AND THEIR USE |
WO2011107494A1 (de) | 2010-03-03 | 2011-09-09 | Sanofi | Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
US8933024B2 (en) | 2010-06-18 | 2015-01-13 | Sanofi | Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases |
US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
TW201215388A (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
WO2012120056A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
US8901114B2 (en) | 2011-03-08 | 2014-12-02 | Sanofi | Oxathiazine derivatives substituted with carbocycles or heterocycles, method for producing same, drugs containing said compounds, and use thereof |
US8828994B2 (en) | 2011-03-08 | 2014-09-09 | Sanofi | Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
WO2012120053A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
WO2012120055A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
EP2714668B9 (de) * | 2011-05-23 | 2017-06-14 | Merck Patent GmbH | Thiazolderivate |
WO2013037390A1 (en) | 2011-09-12 | 2013-03-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
EP2760862B1 (de) | 2011-09-27 | 2015-10-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridin-4-carbonsäureamidderivate als kinaseinhibitoren |
CN105338812A (zh) * | 2013-03-15 | 2016-02-17 | 怀特黑德生物医学研究院 | 苯并咪唑衍生物及其用途 |
EP4197596A1 (de) | 2021-12-15 | 2023-06-21 | Eberhard Karls Universität Tübingen Medizinische Fakultät | Imidazolderivate zur behandlung und prophylaxe von infektionskrankheiten |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5658889A (en) * | 1989-01-24 | 1997-08-19 | Gensia Pharmaceuticals, Inc. | Method and compounds for aica riboside delivery and for lowering blood glucose |
US5628889A (en) * | 1994-09-06 | 1997-05-13 | International Business Machines Corporation | High power capacity magnetron cathode |
AU1811397A (en) * | 1996-02-29 | 1997-09-16 | Kissei Pharmaceutical Co. Ltd. | Imidazole derivatives and vascular wall thickening inhibitor |
JPH11147823A (ja) * | 1997-11-17 | 1999-06-02 | Kissei Pharmaceut Co Ltd | 血管新生阻害剤 |
CN1215076C (zh) * | 1998-09-09 | 2005-08-17 | 症变治疗公司 | 新的果糖1,6-二磷酸酶的杂芳族抑制剂 |
WO2001060819A1 (fr) | 2000-02-18 | 2001-08-23 | Kirin Beer Kabushiki Kaisha | Nouveaux composes d'isoxazole et de thiazole et leur utilisation en tant que medicaments |
EP1752450A1 (de) * | 2005-08-01 | 2007-02-14 | Merck Sante | Imidazolderivate als Fruktose-1,6-biphosphataseinhibitoren und pharmazeutische Zusammensetzungen diese enthaltend |
FR2889190A1 (fr) | 2005-08-01 | 2007-02-02 | Merck Sante Soc Par Actions Si | Nouveaux derives d'imidazoles carboxamides comme inhibiteurs de fructose -1,6-biphosphatase et compositions pharmaceutiques les contenant |
-
2005
- 2005-08-01 FR FR0508211A patent/FR2889190A1/fr active Pending
-
2006
- 2006-07-07 ES ES06776141T patent/ES2326237T3/es active Active
- 2006-07-07 CN CNA2006800281348A patent/CN101233114A/zh active Pending
- 2006-07-07 AT AT06776141T patent/ATE432925T1/de not_active IP Right Cessation
- 2006-07-07 US US11/997,514 patent/US8362057B2/en not_active Expired - Fee Related
- 2006-07-07 BR BRPI0614496-9A patent/BRPI0614496A2/pt not_active Application Discontinuation
- 2006-07-07 CA CA2617282A patent/CA2617282C/en not_active Expired - Fee Related
- 2006-07-07 KR KR1020087005113A patent/KR20080033489A/ko not_active Application Discontinuation
- 2006-07-07 JP JP2008524380A patent/JP5026421B2/ja not_active Expired - Fee Related
- 2006-07-07 EP EP06776141A patent/EP1910310B1/de not_active Not-in-force
- 2006-07-07 DE DE602006007148T patent/DE602006007148D1/de active Active
- 2006-07-07 WO PCT/EP2006/006643 patent/WO2007014619A1/en active Application Filing
- 2006-07-07 AU AU2006275172A patent/AU2006275172B2/en not_active Ceased
- 2006-07-07 MX MX2008001489A patent/MX2008001489A/es not_active Application Discontinuation
- 2006-07-31 AR ARP060103321A patent/AR055202A1/es unknown
-
2008
- 2008-02-29 ZA ZA200801945A patent/ZA200801945B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
FR2889190A1 (fr) | 2007-02-02 |
AR055202A1 (es) | 2007-08-08 |
AU2006275172B2 (en) | 2011-11-24 |
EP1910310B1 (de) | 2009-06-03 |
KR20080033489A (ko) | 2008-04-16 |
CA2617282A1 (en) | 2007-02-08 |
ES2326237T3 (es) | 2009-10-05 |
JP5026421B2 (ja) | 2012-09-12 |
CN101233114A (zh) | 2008-07-30 |
DE602006007148D1 (de) | 2009-07-16 |
CA2617282C (en) | 2014-09-09 |
BRPI0614496A2 (pt) | 2011-03-29 |
AU2006275172A1 (en) | 2007-02-08 |
MX2008001489A (es) | 2008-02-15 |
WO2007014619A1 (en) | 2007-02-08 |
JP2009502992A (ja) | 2009-01-29 |
US20080207720A1 (en) | 2008-08-28 |
EP1910310A1 (de) | 2008-04-16 |
US8362057B2 (en) | 2013-01-29 |
ATE432925T1 (de) | 2009-06-15 |
WO2007014619A8 (en) | 2007-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200801945B (en) | Novelimidazolecarboxamide derivatives as fructose-1,6-bisphosphatase inhibitors, and pharmaceutical compositions comprising same | |
HK1244267A1 (zh) | 包含(r)-n-甲基納曲酮的藥物組合物 | |
IL190292A (en) | History of pyridopyrimidinone and their pharmaceutical preparations | |
EP1858521A4 (de) | Verbindungen und zusammensetzungen als proteinkinase-hemmer | |
IL205510A0 (en) | Benzimidazoledihydrothiadiazinone derivatives as fructose - 1, 6 - bisphosphatase inhibitors, and pharmaceutical compositions comprising same | |
PL1891066T3 (pl) | Związki i kompozycje jako inhibitory kinazy białkowej | |
EP1841431A4 (de) | Verbindungen und zusammensetzungen als proteinkinase-hemmer | |
IL194546A0 (en) | Arylaminopyridine derivatives and pharmaceutical compositions containing them | |
ZA200804305B (en) | Pharmaceutical compositions comprising buprenorphine | |
GB0524962D0 (en) | Topical pharmaceutical compositions | |
IL197933A (en) | Knaase inhibitors, pharmaceuticals containing them and their uses | |
IL193772A0 (en) | 4-oxoquinoline derivatives,methods for the preparation thereof and pharmaceutical compositions containing the same | |
HK1127592A1 (en) | (r)-arylkylamino derivatives and pharmaceutical compositions containing them (r)- | |
IL188352A0 (en) | Pharmaceutical compositions | |
IL186336A0 (en) | Pharmaceutical composition | |
IL187748A0 (en) | Pharmaceutical compositions containing misoprostal | |
IL193211A (en) | Derivatives of Indzol-Troaril and pharmaceutical preparations containing them | |
ZA200804103B (en) | Pharmaceutical compositions | |
PL1707564T3 (pl) | Pochodne indanylopiperazyn, sposób ich wytwarzania i zawierające je kompozycje farmaceutyczne | |
EP1937255A4 (de) | Pharmazeutische zusammensetzung | |
EP1862184A4 (de) | Pharmazeutische zusammensetzung | |
GB0522045D0 (en) | Pharmaceutical compositions | |
IL192091A0 (en) | Pharmaceutical compositions | |
EP1845944A4 (de) | Pharmazeutische zusammensetzungen | |
IL192097A0 (en) | Soluble il-17rc variant, its preparation and pharmaceutical compositions containing them |